Short Term Refractive and Ocular Parameter Changes After Topical Atropine

B

Buddhist Tzu Chi Medical Foundation

Status

Completed

Conditions

Myopia, Left Eye

Treatments

Drug: 0.125% Atropine

Study type

Interventional

Funder types

Other

Identifiers

NCT03839888
BuddhistTCGHTaipei2

Details and patient eligibility

About

In order we had designed a prospective clinical trial. Spherical equivalent refractive error (SER), axial length (AL), mean keratometric value (Mean-K), anterior chamber depth (ACD), and intraocular pressure (IOP) were measured at baseline and one week after topical use of 0.125% atropine. Postcycloplegic changes of refractive error and ocular parameters were evaluated, and their correlations were analyzed with multiple linear regression models.

Enrollment

96 patients

Sex

All

Ages

3 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients who had an SER of -0.5 diopters or less in their eyes.

Exclusion criteria

Patients who had already been undergoing cycloplegic treatment for myopia before.

Trial design

96 participants in 1 patient group

0.125% atropine group
Experimental group
Description:
patients used the 0.125 % atropine eyedrop every night before sleep for 7 days
Treatment:
Drug: 0.125% Atropine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems